787
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Prevalence of gastro-intestinal Symptoms Among COVID-19 Patients and the Association With Disease Clinical Outcomes

ORCID Icon, , , &
Article: FSO858 | Received 03 Mar 2023, Accepted 11 Apr 2023, Published online: 21 Apr 2023

References

  • WeissSR , Navas-MartinS. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiology and Molecular Biology Reviews69(4), 635–664 (2005).
  • ZachariahP , JohnsonCL , HalabiKCet al.Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children's hospital in New York City, New York. JAMA pediatrics.174(10), e202430–e202430 (2020).
  • LaiC-C , ShihT-P , KoW-C , TangH-J , HsuehP-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. of antimicrobial agents.55(3), 105924 (2020).
  • SinghS , McnabC , OlsonRMet al.How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic. Lancet.398(10316), 2109–2124 (2021).
  • UmakanthanS , SahuP , RanadeAVet al.Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgraduate medical journal.96(1142), 753–758 (2020).
  • GuanY , ZhengB , HeYet al.Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science302(5643), 276–278 (2003).
  • WooPC , LauSK , ChuC-met al.Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol.79(2), 884–895 (2005).
  • LuR , ZhaoX , LiJet al.Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet.395(10224), 565–574 (2020).
  • CuiJ , LiF , ShiZ-L. Origin and evolution of pathogenic coronaviruses. Nature reviews microbiology.17(3), 181–192 (2019).
  • VermicelliS , CricelliL , GrimaldiM. How can crowdsourcing help tackle the COVID-19 pandemic? An explorative overview of innovative collaborative practices. R&D Management.51(2), 183–194 (2021).
  • LeTT , AndreadakisZ , KumarAet al.The COVID-19 vaccine development landscape. Nat. Rev. Drug Discov.19(5), 305–306 (2020).
  • ChoiWS , CheongHJ. COVID-19 vaccination for people with comorbidities. Infection & Chemotherapy.53(1), 155 (2021).
  • UmakanthanS , SenthilS , JohnSet al.The effect of statins on clinical outcome among hospitalized patients with COVID-19: a multi-centric cohort study. Frontiers in pharmacology, 13, 2558 (2022).
  • UmakanthanS , PatilS , SubramaniamN , SharmaR. COVID-19 vaccine hesitancy and resistance in India explored through a population-based longitudinal survey. Vaccines.9(10), 1064 (2021).
  • SallamM. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines.9(2), 160 (2021).
  • UmakanthanS , LawrenceS. Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study. Postgraduate Medical Journal.98(1164), 756–764 (2022).
  • NuwardaRF , RamzanI , WeekesL , KayserV. Vaccine hesitancy: contemporary issues and historical background. Vaccines.10(10), 1595 (2022).
  • HuangC , WangY , LiXet al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet.395(10223), 497–506 (2020).
  • SikachiR , AgrawalA. Whole body point-care ultrasound for COVID-19: a multi-system approach to a multi-system disease. Anaesthesia75(8), 1114–1115 (2020).
  • BeyerstedtS , CasaroEB , RangelÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. European Journal of Clinical Microbiology & Infectious Diseases.40, 905–919 (2021).
  • NiW , YangX , YangDet al.Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care.24(1), 1–10 (2020).
  • WongSH , LuiRN , SungJJ. Covid-19 and the digestive system. J. Gastroenterol. Hepatol.35(5), 744–748 (2020).
  • TargońskiR , GąseckaA , ProwanckiA , TargońskiR. An alternative to airborne droplet transmission route of SARS-CoV-2, the feco-oral route, as a factor shaping COVID-19 pandemic. Med. Hypotheses166, 110903 (2022).
  • PanL , MuM , YangPet al.Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. The American journal of gastroenterology.115, (2020).
  • WangD , HuB , HuCet al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA323(11), 1061–1069 (2020).
  • WanY , LiJ , ShenLet al.Enteric involvement in hospitalised patients with COVID-19 outside Wuhan. The Lancet Gastroenterology & Hepatology.5(6), 534–535 (2020).
  • GroffA , KavanaughM , RamgobinDet al.Gastrointestinal manifestations of COVID-19: a review of what we know. Ochsner Journal.21(2), 177–180 (2021).
  • WangM-K , YueH-Y , CaiJet al.COVID-19 and the digestive system: a comprehensive review. World Journal of Clinical Cases.9(16), 3796 (2021).
  • ElshazliRM , KlineA , ElgamlAet al.Gastroenterology manifestations and COVID-19 outcomes: a meta-analysis of 25,252 cohorts among the first and second waves. J. Med. Virol.93(5), 2740–2768 (2021).
  • DorrellRD , DoughertyMK , BarashEL , LichtigAE , ClaytonSB , JensenET. Gastrointestinal and hepatic manifestations of COVID-19: a systematic review and meta-analysis. Jgh Open.5(1), 107–115 (2021).
  • UmakanthanS , BukeloMM , GajulaSS. The Commonwealth Caribbean COVID-19: regions resilient pathway during pandemic. Frontiers in Public Health.10, 844333 (2022).
  • HajjoR , AbuAlSamenMM , AlzoubiHM , AlqutobR. The Epidemiology of Hundreds of Individuals Infected with Omicron BA. 1 in Middle-Eastern Jordan. medRxiv, 2022.2001.2023.22269442 (2022).
  • National Institutes of Health NIH. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. (2022). www.covid19treatmentguidelines.nih.gov/
  • YoungBE , OngSWX , KalimuddinSet al.Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA323(15), 1488–1494 (2020).
  • ZhangJ-J , DongX , CaoY-yet al.Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy75(7), 1730–1741 (2020).
  • ReddW , ZhouJ , HathornKe MTet al.Prevalence and characteristics of gastrointestinal symptoms in patients with sars-cov-2 infection in the united states: a multicenter cohort study. Gastroenterology, 195, 765–772 (2020).
  • ShehabM , AlrashedF , ShuaibiS , AlajmiD , BarkunA. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis. BMJ open gastroenterology.8(1), e000571 (2021).
  • DamasoCR , OliveiraMF , MassaraniSM , MoussatchéN. Azathioprine inhibits vaccinia virus replication in both BSC-40 and RAG cell lines acting on different stages of virus cycle. Virology300(1), 79–91 (2002).
  • UnoY. Why does SARS-CoV-2 invade the gastrointestinal epithelium?Gastroenterology159(4), 1622–1623 (2020).
  • JinX , LianJ-S , HuJ-Het al.Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut69(6), 1002–1009 (2020).
  • ZhangH , LiH-B , LyuJ-Ret al.Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. International Journal of Infectious Diseases.96, 19–24 (2020).
  • SifrimD , CastellD , DentJ , KahrilasPJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut53(7), 1024–1031 (2004).
  • HerbellaFA , PattiMG. Gastroesophageal reflux disease: from pathophysiology to treatment. World J. Gastroenterol.16(30), 3745–3749 (2010).
  • ZerbibF , Bruleydes Varannes S , RomanSet al.Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian–French cohort of healthy subjects. Aliment. Pharmacol. Ther.22(10), 1011–1021 (2005).
  • BoeckxstaensG , El-SeragHB , SmoutAJ , KahrilasPJ. Symptomatic reflux disease: the present, the past and the future. Gut63(7), 1185–1193 (2014).
  • AmirianES. Potential fecal transmission of SARS-CoV-2: current evidence and implications for public health. International journal of infectious diseases.95, 363–370 (2020).
  • JeffersonT , SpencerE , BrasseyJ , HeneghanC. Viral cultures for COVID-19 infectivity assessment–a systematic review (Update 4). Clinical Infectious Diseases, 73, e3884–e3899 (2020).
  • ChenL , LouJ , BaiY , WangM. COVID-19 disease with positive fecal and negative pharyngeal and sputum viral tests. The American journal of gastroenterology.115, 790 (2020).
  • Al-MomaniH , PerryA , StewartCet al.Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients. Scientific reports.6, 26985 (2016).
  • Al-MomaniH , PerryA , JonesRet al.Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis. Scientific reports.7, 46546 (2017).
  • RosenR , HuL , AmiraultJ , KhatwaU , WardDV , OnderdonkA. 16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora. The Journal of pediatrics.166(4), 917–923 (2015).
  • ZhouF , YuT , DuRet al.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet.395(10229), 1054–1062 (2020).
  • YeQ , WangB , ZhangT , XuJ , ShangS. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. Am. J. Physiol. Gastrointestinal and Liver Physiol.319(2), G245–G252 (2020).
  • HanC , DuanC , ZhangSet al.Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am. J. Gastroenterology.6, 916–923 (2020).
  • GuJ , HanB , WangJ. COVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology158(6), 1518–1519 (2020).
  • JinB , SinghR , HaSE , ZoggH , ParkPJ , RoS. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World journal of gastroenterology.27(19), 2341 (2021).